BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33889265)

  • 1. Hepatocellular carcinoma in Senegal: epidemiological, clinical and etiological aspects about 229 cases at
    Diallo I; Ndiaye B; Touré M; Sow A; Mbengue A; Diawara PS; Gning SB; Mbaye PS; Fall F; Mbengue M
    Pan Afr Med J; 2021; 38():99. PubMed ID: 33889265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study.
    Ramírez Mena A; Thiam M; Ka D; Niang I; Tine J; Fortes L; Ndiaye K; Ndiaye O; Fall M; Gaye A; Ngom NF; Fall F; Berzigotti A; Kirk GD; Jaquet A; Seydi M; Wandeler G;
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):539-549. PubMed ID: 38588691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India.
    Sood A; Midha V; Goyal O; Goyal P; Sood N; Sharma SK
    Indian J Gastroenterol; 2014 Jan; 33(1):35-40. PubMed ID: 24222369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
    Poh Z; Goh BB; Chang PE; Tan CK
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
    Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
    Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
    Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral Hepatitis B: clinical, paraclinical and evolutionary features within the Hepatogastroenterology Department at the Aristide Le Dantec Hospital: about 728 cases].
    Diallo S; Bassène ML; Gueye MN; Thioubou MA; Dia D; Mbengue M; Diouf ML
    Pan Afr Med J; 2018; 31():82. PubMed ID: 31011383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactive hepatitis B carriers: outcomes of patients followed at Hôpital Principal de Dakar, Senegal.
    Diallo I; Ndiaye B; Fall CA; Mbaye M; Korch I; Diawara PS; Mbengue A; Gning SB; Mbaye PS; Fall F
    Pan Afr Med J; 2018; 31():49. PubMed ID: 30918575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of liver cirrhosis over ten consecutive years in Southern China.
    Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
    World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
    Elzouki AN; Eriksson S
    Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients].
    Said Y; Debbeche R; Ben Ali Z; Bouzid K; Trabelsi S; Bouzaidi S; Salem M; Rajhi H; Kouni Chahed M; Najjar T
    Tunis Med; 2012 Jun; 90(6):468-72. PubMed ID: 22693088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological Characteristics of Advanced Hepatocellular Carcinoma in the Northern Region of Vietnam.
    Le VQ; Nguyen VH; Nguyen VH; Nguyen TL; Sudenga SL; Trinh LH; Nguyen VT; Nguyen TTH
    Cancer Control; 2019; 26(1):1073274819862793. PubMed ID: 31290350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia.
    Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):541-546. PubMed ID: 32660841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
    Zhao H; Zhu P; Han T; Ye Q; Xu C; Wu L; Liu F; Yin W; Li Z; Guo Y
    J Clin Lab Anal; 2020 Feb; 34(2):e23075. PubMed ID: 31659795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.
    Benvegnù L; Noventa F; Bernardinello E; Pontisso P; Gatta A; Alberti A
    Gut; 2001 Jan; 48(1):110-5. PubMed ID: 11115831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
    Hallager S; Ladelund S; Kjaer M; Madsen LG; Belard E; Laursen AL; Gerstoft J; Røge BT; Grønbaek KE; Krarup HB; Christensen PB; Weis N
    J Viral Hepat; 2018 Jan; 25(1):47-55. PubMed ID: 28750141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis.
    Sangiovanni A; Alimenti E; Gattai R; Filomia R; Parente E; Valenti L; Marzi L; Pellegatta G; Borgia G; Gambato M; Terreni N; Serio I; Belli L; Oliveri F; Maimone S; Brunacci M; D'Ambrosio R; Forzenigo LV; Russo FP; Rumi M; Barone M; Fracanzani AL; Raimondo G; Giannini EG; Brunetto MR; Villa E; Biganzoli E; Colombo M; Lampertico P
    J Hepatol; 2020 Sep; 73(3):593-602. PubMed ID: 32243959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia associates with increased risk of hepatocellular carcinoma among male patients with cirrhosis.
    Feng Z; Zhao H; Jiang Y; He Z; Sun X; Rong P; Wang W
    Clin Nutr; 2020 Oct; 39(10):3132-3139. PubMed ID: 32057535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.